Qlucore Receives R&D Funding
News Apr 29, 2013
Qlucore announces it will develop an enhanced NGS-enabled release of Qlucore Omics Explorer. A recent grant awarded by VINNOVA, the Swedish Governmental Agency for Innovation Systems, now makes it possible for Qlucore to implement its NGS solution.
Genome research has advanced significantly in recent years, and the ability to determine the entire DNA of a person for $1,000 will soon be reached. This technological revolution, known as "Next Generation Sequencing" (NGS), will be a paradigm shift for biomedical research, industry and healthcare. This shift will move the bottleneck from data generation to data analysis and interpretation. Qlucore is at the forefront of commercial software development for the analysis of genomic data sets. The firm has an impressive customer base, including several of the world's largest pharmaceutical companies and prestigious international research institutions, in more than 20 countries.
Qlucore will extend it's current Omics Explorer platform with a new product module for the fast, user-friendly and interactive analysis of NGS data. The product module will be for users such as biologists and scientific researchers, and will differ from other solutions currently on the market, as existing solutions typically require an experienced data analyst or bioinformatician.. Qlucore's unique approach makes it possible for more users to perform analysis themselves, and increases the likelihood of innovative and better results both within the scientific research and healthcare fields. Development and innovation will be driven by Qlucore in cooperation with world leading scientists at Sweden's Lund University.
"Qlucore Omics Explorer is currently aiding scientists around the world to visually analyze a wide range of data types from genetic and protein related experiments. With this support from VINNOVA we will give scientists the same user experience for NGS data analysis. We will deliver a new and powerful user analysis experience." says Carl-Johan Ivarsson, President, Qlucore.
Scientists working in a range of disciplines joined forces to identify a new approach to combat African sleeping sickness. Their research revealed a promising strategy to develop a suitable agent. This novel concept could also be employed in the future rational design of drugs for the treatment of other diseases.READ MORE